1. Increasing Use of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients Age 70 Years and Older: A CIBMTR Study of Trends and Outcomes 
Lori Muffly, MD, MS, Marcelo C. Pasquini, MD, MS, Michael Martens, PhD, Ruta Brazauskas, PhD, Xiaochun Zhu, MS, Kehinde Adekola, MD, Mahmoud D. Aljurf, MD, MPH, Andrew S. Artz, MD, MS, Ashish Bajel, MBBS, FRACP, FRCPA, Karen K. Ballen, MD, Minoo Battiwalla, MD, MS, Amer Beitinjaneh, MD, MPH, MS, Jean-Yves Cahn, MD, Matthew Carabasi, MD, Yi-Bin Chen, MD, Saurabh Chhabra, MD, Stefan O. Ciurea, MD, Edward A. Copelan, MD, Anita D'Souza, MD, John Edwards, MD, Cesar O. Freytes, MD, Henry C. Fung, MD, Robert Peter Gale, MD, PhD, Sergio A. Giralt, MD, Shahrukh K. Hashmi, MD, MPH, Peiman Hematti, MD, Gerhard C. Hildebrandt, MD, Vincent T. Ho, MD, Ann A. Jakubowski, PhD, MD, Hillard M. Lazarus, MD, Philip L. McCarthy, MD, Rebecca L. Olin, MD, MSCE, Richard Olsson, MD, PhD, Andrew Rezvani, David A. Rizzieri, MD, Matthew Seftel, Sachiko Seo, MD, PhD, Mohamed L. Sorror, MD, MSc, Jeffrey Szer, MBBS, William A. Wood, MD, MPH 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S68-S69 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Absolute number of allogeneic transplants in recipients 70 years and older from 2000 to 2013 reported to the CIBMTR by disease category.
Biology of Blood and Marrow Transplantation  , S68-S69DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
OS for allogeneic HCT recipients 70 years and older transplanted between and
Biology of Blood and Marrow Transplantation  , S68-S69DOI: ( /j.bbmt )
Copyright © Terms and Conditions